Skip to main content
logo
Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
1.900
-0.100 (-5.00%)
May 13, 2026, 3:48 PM EST

Interpace Biosciences Revenue

In the year 2025, Interpace Biosciences had annual revenue of $38.73M, down -17.47%. Interpace Biosciences had revenue of $9.22M in the quarter ending December 31, 2025, a decrease of -25.68%.

Revenue
38.73M
Revenue Growth
-17.47%
P/S Ratio
1.45
Revenue / Employee
355.34K
Employees
102
Market Cap
52.63M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202538.73M-8.20M-17.47%
Dec 31, 202446.93M6.89M17.21%
Dec 31, 202340.04M8.20M25.75%
Dec 31, 202231.84M-1.28M-3.86%
Dec 31, 202133.12M719.00K2.22%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Global Cord Blood196.10M
Centogene53.65M
Bioqual42.35M
Psychemedics19.69M
Aspira Women's Health9.22M
ProPhase Labs4.90M
Longduoduo Company2.72M
InVitro International811.29K
Revenue Rankings

Interpace Biosciences News

More News